34 results on '"Korpi, Esa R."'
Search Results
2. Brain regional μ-opioid receptor function in rat lines selected for differences in alcohol preference
- Author
-
Soini, Sanna L, Hyytiä, Petri, and Korpi, Esa R
- Published
- 2002
- Full Text
- View/download PDF
3. Increased behavioral neurosteroid sensitivity in a rat line selectively bred for high alcohol sensitivity
- Author
-
Korpi, Esa R., Mäkelä, Riikka, Romeo, Elena, Guidotti, Alessandro, Uusi-Oukari, Mikko, Furnari, Carmelo, di Michele, Flavia, Sarviharju, Maija, Xu, Mei, and Rosenberg, Per H.
- Published
- 2001
- Full Text
- View/download PDF
4. Coupling between agonist and chloride ionophore sites of the GABA A receptor: agonist/antagonist efficacy of 4-PIOL
- Author
-
Rabe, Holger, Picard, Raymonde, Uusi-Oukari, Mikko, Hevers, Wulf, Lüddens, Hartmut, and Korpi, Esa R.
- Published
- 2000
- Full Text
- View/download PDF
5. Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study
- Author
-
Panhelainen, Anne E. and Korpi, Esa R.
- Subjects
- *
TRANQUILIZING drugs , *SEDATIVES -- Overdose , *HYPNOTISM , *DIAZEPAM , *IMMUNOHISTOCHEMISTRY , *ANXIETY , *LABORATORY mice - Abstract
Abstract: The classical benzodiazepine diazepam (DZ) induces anxiolysis at low doses and sedation and hypnosis at higher doses. Different brain areas and neuronal populations most likely mediate these different behavioral effects. We used c-Fos immunohistochemistry as an indirect way to study neuronal activation or inhibition induced by DZ at anxiolytic and sedative doses (0.5 and 5mg/kg, respectively) in various brain areas involved in anxiety, arousal, sedation and addiction in C57BL/6J mice. We also focused on the two neuronal populations, orexinergic and dopaminergic neuronal populations, with the help of double-immunohistochemistry using c-Fos and orexin-A antibodies and c-Fos and tyrosine hydroxylase antibodies. We found that different brain areas of unhabituated mice reacted differently to the mild stress induced by vehicle injection. Also the response to anxiolytic or sedative doses of DZ differed between the areas, suggesting that distinct brain areas mediate the behavioral effects of low and high DZ doses. Our findings propose a role for inhibition of orexin neurons in the anxiolytic and sleep-promoting effects of DZ. In addition, the activation of central amygdala neurons by DZ treatment was associated with anxiolytic and sedative effects. On the other hand, the ventral hippocampus, basolateral amygdala, ventral tegmental area and prefrontal cortex were sensitive even to the mild injection stress, but not to the anxiolytic dose of DZ. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
6. Does ethanol act preferentially via selected brain GABAA receptor subtypes? the current evidence is ambiguous
- Author
-
Korpi, Esa R., Debus, Fabian, Linden, Anni-Maija, Malécot, Cécile, Leppä, Elli, Vekovischeva, Olga, Rabe, Holger, Böhme, Ingo, Aller, M. Isabel, Wisden, William, and Lüddens, Hartmut
- Subjects
- *
GABA , *ALCOHOL , *AUDITORY pathways , *BENZODIAZEPINES - Abstract
Abstract: In rodent models, γ-aminobutyric acid A (GABAA) receptors with the α6 and δ subunits, expressed in the cerebellar and cochlear nucleus granule cells, have been linked to ethanol sensitivity and voluntary ethanol drinking. Here, we review the findings. When considering both in vivo contributions and data on cloned receptors, the evidence for direct participation of the α6-containing receptors to increased ethanol sensitivity is poor. The α6 subunit-knockout mouse lines do not have any changed sensitivity to ethanol, although these mice do display increased benzodiazepine sensitivity. However, in general the compensations occurring in knockout mice (regardless of which particular gene is knocked out) tend to fog interpretations of drug actions at the systems level. For example, the α6 knockout mice have increased TASK-1 channel expression in their cerebellar granule cells, which could influence sensitivity to ethanol in the opposite direction to that obtained with the α6 knockouts. Indeed, TASK-1 knockout mice are more impaired than wild types in motor skills when given ethanol; this might explain why GABAA receptor α6 knockout mice have unchanged ethanol sensitivities. As an alternative to studying knockout mice, we examined the claimed δ subunit-dependent/γ2 subunit-independent ethanol/[3H]Ro 15-4513 binding sites on GABAA receptors. We looked at [3H]Ro 15-4513 binding in HEK 293 cell membrane homogenates containing rat recombinant α6/4β3δ receptors and in mouse brain sections. Specific high-affinity [3H]Ro 15-4513 binding could not be detected under any conditions to the recombinant receptors or to the cerebellar sections of γ2(F77I) knockin mice, nor was this binding to brain sections of wild-type C57BL/6 inhibited by 1–100mM ethanol. Since ethanol may act on many receptor and channel protein targets in neuronal membranes, we consider the α6 (and α4) subunit-containing GABAA receptors unlikely to be directly responsible for any major part of ethanol''s actions. Therefore, we finish the review by discussing more generally alcohol and GABAA receptors and by suggesting potential future directions for this research. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
7. Alcohol drinking of alcohol-preferring AA rats is differentially affected by clozapine and olanzapine
- Author
-
Ingman, Kimmo and Korpi, Esa R.
- Subjects
- *
ALCOHOL , *CLOZAPINE , *OLANZAPINE , *ANTIDEPRESSANTS - Abstract
Abstract: Clinical evidence suggests that atypical antipsychotic drugs might reduce alcohol drinking and help to maintain abstinence. This study aimed to compare the effects of two widely used atypical antipsychotic drugs clozapine and olanzapine on alcohol intake in alcohol-preferring AA (Alko, Alcohol) rats that were taught to drink 10% alcohol in a 4 h limited access paradigm. Effects of acute clozapine (0, 0.3, 1.0 and 5.0 mg/kg) and olanzapine (0, 0.1, 0.5 and 1.25 mg/kg) treatments on the limited access alcohol drinking were studied. In repeated treatment experiment, clozapine (1.0 mg/kg) or olanzapine (0.5 mg/kg) was administered once daily, before limited access alcohol drinking session, over 5 successive days. To reveal any effect of the drugs selective for alcohol drinking, alcohol was exchanged with 0.1% saccharin solution for the 4 h limited access, and acute treatments were repeated. Effects of the drugs on ambulatory locomotor activity were tested with doses that were used in the acute experiments. Acute clozapine treatment had no effect on either alcohol or saccharin drinking, but olanzapine significantly reduced 4 h alcohol drinking. Repeated olanzapine treatment significantly reduced 4 h alcohol drinking when compared with vehicle or clozapine, but a tolerance developed to this effect. Repeated clozapine treatment produced no significant effect compared with vehicle. Both drugs significantly reduced locomotor activity. In conclusion, the atypical antipsychotic olanzapine non-selectively reduced alcohol drinking, while clozapine failed to do so, even if both were administered at pharmacologically effective doses. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
8. GABAA receptor subtypes as targets for neuropsychiatric drug development
- Author
-
Korpi, Esa R. and Sinkkonen, Saku T.
- Subjects
- *
GABA , *ALCOHOL drinking , *DRUG development , *GENETIC polymorphisms - Abstract
Abstract: The main inhibitory neurotransmitter system in the brain, the γ-aminobutyric acid (GABA) system, is the target for many clinically used drugs to treat, for example, anxiety disorders and epilepsy and to induce sedation and anesthesia. These drugs facilitate the function of pentameric A-type GABA (GABAA) receptors that are extremely widespread in the brain and composed from the repertoire of 19 subunit variants. Modern genetic studies have found associations of various subunit gene polymorphisms with neuropsychiatric disorders, including alcoholism, schizophrenia, anxiety, and bipolar affective disorder, but these studies are still at their early phase because they still have failed to lead to validated drug development targets. Recent neurobiological studies on new animal models and receptor subunit mutations have revealed novel aspects of the GABAA receptors, which might allow selective targeting of the drug action in receptor subtype-selective fashion, either on the synaptic or extrasynaptic receptor populations. More precisely, the greatest advances have occurred in the clarification of the molecular and behavioral mechanisms of action of the GABAA receptor agonists already in the clinical use, such as benzodiazepines and anesthetics, rather than in the introduction of novel compounds to clinical practice. It is likely that these new developments will help to overcome the present problems of the chronic treatment with nonselective GABAA agonists, that is, the development of tolerance and dependence, and to focus the drug action on the neurobiologically and neuropathologically relevant substrates. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
9. Drug interactions at GABAA receptors
- Author
-
Korpi, Esa R., Gründer, Gerhard, and Lüddens, Hartmut
- Subjects
- *
GABA receptors , *DRUG interactions - Abstract
Neurotransmitter receptor systems have been the focus of intensive pharmacological research for more than 20 years for basic and applied scientific reasons, but only recently has there been a better understanding of their key features. One of these systems includes the type A receptor for the γ-aminobutyric acid (GABA), which forms an integral anion channel from a pentameric subunit assembly and mediates most of the fast inhibitory neurotransmission in the adult vertebrate central nervous system. Up to now, depending on the definition, 16–19 mammalian subunits have been cloned and localized on different genes. Their assembly into proteins in a poorly defined stoichiometry forms the basis of functional and pharmacological GABAA receptor diversity, i.e. the receptor subtypes. The latter has been well documented in autoradiographic studies using ligands that label some of the receptors’ various binding sites, corroborated by recombinant expression studies using the same tools. Significantly less heterogeneity has been found at the physiological level in native receptors, where the subunit combinations have been difficult to dissect.This review focuses on the characteristics, use and usefulness of various ligands and their binding sites to probe GABAA receptor properties and to gain insight into the biological function from fish to man and into evolutionary conserved GABAA receptor heterogeneity. We also summarize the properties of the novel mouse models created for the study of various brain functions and review the state-of-the-art imaging of brain GABAA receptors in various human neuropsychiatric conditions.The data indicate that the present ligands are only partly satisfactory tools and further ligands with subtype-selective properties are needed for imaging purposes and for confirming the behavioral and functional results of the studies presently carried out in gene-targeted mice with other species, including man. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
10. Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors.
- Author
-
Mansikkamäki, Salla, Sinkkonen, Saku T., Korpi, Esa R., and Lüddens, Hartmut
- Subjects
- *
NONSTEROIDAL anti-inflammatory agents , *GABA receptors , *TARGETED drug delivery , *PICROTOXININ , *BINDING sites - Abstract
The nonsteroidal anti-inflammatory drug (NSAID) niflumic acid, a fenamate in structure, has many molecular targets, one of them being specific subtypes of the main inhibitory ligand-gated anion channel, the GABA A receptor. Here, we report on the effects of other fenamates and other classes of NSAIDs on brain picrotoxinin-sensitive GABA A receptors, using an autoradiographic assay with [35S]TBPS as a ligand on mouse brain sections. We found that the other fenamates studied (flufenamic acid, meclofenamic acid, mefenamic acid and tolfenamic acid) affected the autoradiographic signal at low micromolar concentrations in a facilitatory-like allosteric fashion, i.e., without having affinity to the [35S]TBPS binding site. Unlike niflumic acid that shows clear preference for inhibiting cerebellar granule cell layer GABA A receptors, the other fenamates showed little brain regional selectivity, indicating that their actions are not receptor-subtype selective. Of the non-fenamate NSAIDs studied at 100 μM concentration, diclofenac induced the greatest inhibition of the binding, which is not surprising as it has close structural similarity with the potent fenamate meclofenamic acid. Using two-electrode voltage-clamp assays on Xenopus oocytes, the effect of niflumic acid was found to be dependent on the β subunit variant and the presence of γ2 subunit in rat recombinant α1β and α1βγ2 GABA A receptors, with the β1 allowing the niflumic acid inhibition and β3 the stimulation of the receptor-mediated currents. In summary, the fenamate NSAIDs constitute an interesting class of compounds that could be used for development of potent GABA A receptor allosteric agonists with other targets to moderate inflammation, pain and associated anxiety/depression. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. Characterization of novel ligands for wild-type and natural mutant diazepam-insensitive benzodiazepine receptors
- Author
-
Wong, Garry, Uusi-Oukari, Mikko, Hansen, Holger C., Suzdak, Peter D., and Korpi, Esa R.
- Published
- 1995
- Full Text
- View/download PDF
12. Natural mutation of GABA A receptor α6 subunit alters benzodiazepine affinity but not allosteric GABA effects
- Author
-
Korpi, Esa R. and Seeburg, Peter H.
- Published
- 1993
- Full Text
- View/download PDF
13. Diazepam-insensitive [ 3H]Ro 15-4513 binding in intact cultured cerebellar granule cells
- Author
-
Malminiemi, Outi and Korpi, Esa R.
- Published
- 1989
- Full Text
- View/download PDF
14. Early postnatal treatment with muscimol transiently alters brain GABA A receptors and open-field behavior in rat
- Author
-
Taira, Tomi, Uusi-Oukari, Mikko, and Korpi, Esa R.
- Published
- 1993
- Full Text
- View/download PDF
15. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments
- Author
-
Karoum, Farouk, Korpi, Esa R., Linnoila, Markku, Chuang, Lin-Whei, and Wyatt, Richard Jed
- Published
- 1984
- Full Text
- View/download PDF
16. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: A comparison with peripheral changes
- Author
-
Karoum, Farouk, Korpi, Esa R., Chuang, Lin-Whei, Linnoila, Markku, and Wyatt, Richard Jed
- Published
- 1986
- Full Text
- View/download PDF
17. Reversal of novelty-induced hippocampal c-Fos expression in GluA1 subunit-deficient mice by chronic treatment targeting glutamatergic transmission.
- Author
-
Maksimovic, Milica, Aitta-aho, Teemu, and Korpi, Esa R.
- Subjects
- *
HIPPOCAMPUS (Brain) , *GENE expression , *CHRONIC disease treatment , *NEUROBEHAVIORAL disorders , *TARGETED drug delivery , *EXCITATORY amino acid agents , *LABORATORY mice - Abstract
Malfunction of glutamate transmission is implicated in several neuropsychiatric disorders. Gria1 −/ − mouse line with knocked-out GluA1 subunits of ionotropic AMPA glutamate receptor displays several behavioural features of schizoaffective disorder. Typically, these mice show hyperactivity provoked by environmental novelty, which is attenuated after 4-week treatment with the standard mood-stabilisers lithium and valproate and the mood-stabilising anticonvulsants topiramate and lamotrigine (Maksimovic, M., Vekovischeva, O.Y., Aitta-Aho, T., Korpi, E.R., 2014. Chronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient mice. PloS One. 9, e100188). Here, we complement our study by treating these mice chronically with perampanel, a novel non-competitive antagonist of AMPA receptors, for 4 weeks at the dose of 60 mg/kg diet, and found reduced locomotor hyperactivity in the Gria1 − / − animals, while not affecting the wild-type littermates. To study the cellular mechanism by which chronic treatments with glutamate-modulating mood-stabilizing drugs alleviate this hyperactivity, we used the immediate early gene c-Fos protein expression as a marker of neuronal activity in the brain. Chronic lithium, valproate and topiramate blunted the c-Fos expression especially in the dorsal hippocampus of the Gria1 − / − mice, with all of them reducing the number of c-Fos-positive cells in the CA3 region and valproate and topiramate also in the dentate gyrus (DG). Lamotrigine and perampanel treatments had the same effect in the all CA1, CA3 and DG subfields of the dorsal hippocampus of Gria1−/− mice. The results suggest that abnormal (hippocampal) glutamatergic transmission underlies the hyperactive phenotype of the Gria1−/− mice in a novel environment, and based on the efficacies of the present chronic drug treatments, this mouse model may serve as a predictive tool for studying novel mood-stabilisers. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
18. Activity of BKCa Channel Is Modulated by Membrane Cholesterol Content and Association with Na+/K+-ATPase in Human Melanoma IGR39 Cells.
- Author
-
Tajima, Nobuyoshi, Itokazu, Yutaka, Korpi, Esa R., Somerharju, Pentti, and Käkelä, Reijo
- Subjects
- *
MELANOMA , *CELL proliferation , *CELL growth , *CELL division , *ISOPENTENOIDS , *NEUROENDOCRINE tumors , *ADENOSINE triphosphatase , *CHOLESTEROL - Abstract
Interaction of large conductance Ca2+- and voltage-activated K+ (BKCa) channels with Na+/K+-ATPase, caveolin-1, and cholesterol was studied in human melanoma IGR39 cells. Functional BKCa channels were enriched in caveolin-rich and detergent-resistant membranes, i.e. rafts, and blocking of the channels by a specific BKCa blocker paxilline reduced proliferation of the cells. Disruption of rafts by selective depletion of cholesterol released BKCa channels from these domains with a consequent increase in their activity. Consistently, cholesterol enrichment of the cells increased the proportion of BKCa channels in rafts and decreased their activity. Immunocytochemical analysis showed that BKCa channels co-localize with Na+/K+-ATPase in a cholesterol-dependent manner, thus suggesting their co-presence in rafts. Supporting this, ouabain, a specific blocker of Na+/K+-ATPase, inhibited BKCa whole-cell current markedly in control cells but not in cholesterol-depleted ones. This inhibition required the presence of external Na+. Collectively, these data indicate that the presence of Na+/K+-ATPase in rafts is essential for efficient functioning of BKCa channels, presumably because the pump maintains a low intracellular Na+ proximal to the BKCa channel. In conclusion, cholesterol could play an important role in cellular ion homeostasis and thus modulate many cellular functions and cell proliferation. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
19. Selective reduction of γ-aminobutyric acid type A receptor δ subunit mRNA levels by MK-801 in rat dentate gyrus
- Author
-
Sinkkonen, Saku T., Lindén, Anni-Maija, Korpi, Esa R., and Wong, Garry
- Subjects
- *
GENE expression , *GENETIC regulation , *AMINO acids , *DECARBOXYLASES - Abstract
The influence of excitatory blockade elicited by uncompetitive N-methyl-d-aspartate (NMDA)/glutamate receptor antagonists on inhibitory GABAergic systems is not well understood. Adult male rats were injected i.p. with a single dose of the prototypical uncompetitive antagonist MK-801 (0.2–10 mg/kg) and in situ hybridization was performed to measure mRNA levels of γ-aminobutyric acid type A (GABAA) receptor subunits (α1–6, β1–3, γ1–3, δ, #x03B5;, and θ). A significant decrease in δ subunit mRNA levels, that reached ∼70% of saline-treated values, was observed in the hippocampal dentate gyrus following MK-801 administration. Other subunits did not display statistically significant alterations. These data demonstrate selective actions on GABAA receptor subunit levels that result from blockade of excitation by MK-801. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
20. Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone
- Author
-
den Hollander, Bjørnar, Rozov, Stanislav, Linden, Anni-Maija, Uusi-Oukari, Mikko, Ojanperä, Ilkka, and Korpi, Esa R.
- Subjects
- *
DESIGNER drugs , *PSYCHOTROPIC plants , *DIAGNOSIS of brain diseases , *DRUG efficacy , *NEUROCHEMISTRY , *LABORATORY mice , *NEUROTOXICOLOGY - Abstract
Abstract: Introduction/aims: The use of cathinone-derivative designer drugs methylone and mephedrone has increased rapidly in recent years. Our aim was to investigate the possible long-term effects of these drugs on a range of behavioral tests in mice. Further, we investigated the long-term effects of these drugs on brain neurochemistry in both rats and mice. Methods: We treated animals with a binge-like regimen of methylone or mephedrone (30mg/kg, twice daily for 4days) and, starting 2weeks later, we performed behavioral tests of memory, anxiety and depression and measured brain levels of dopamine (DA), serotonin (5-HT), their metabolites and norepinephrine (NE). 5-HT and DA transporter (5-HTT and DAT) levels were also measured in rats by [3H]paroxetine and [3H]mazindol binding. Results: Mephedrone reduced working memory performance in the T-maze spontaneous alternation task but did not affect neurotransmitter levels aside from a 22% decrease in striatal homovanillic acid (HVA) levels in mice. Methylone had little effect on behavior or neurotransmitter levels in mice but produced a widespread depletion of 5-HT and 5-HTT levels in rats. Conclusions: Both methylone and mephedrone appeared to have a long-term effect on either behavioral or biochemical gauges of neurotoxicity in rodents. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
21. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation
- Author
-
Leppä, Elli, Linden, Anni-Maija, Rabe, Holger, Vekovischeva, Olga Yu., Wulff, Peer, Lüddens, Hartmut, Wisden, William, and Korpi, Esa R.
- Subjects
- *
GABA receptors , *BENZODIAZEPINES , *LIGANDS (Biochemistry) , *SEDATIVES , *HYPNOTICS , *ZOLPIDEM , *AMINOBUTYRIC acid , *NEUROTRANSMITTER receptors , *LABORATORY mice - Abstract
Abstract: The potent sedative-hypnotic zolpidem and the convulsant methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM) act primarily by binding to the benzodiazepine site of the main inhibitory neurotransmitter receptor, the pentameric γ-aminobutyric acid type A receptor (GABAA). This binding depends critically on the wild-type F77 residue of the GABAA receptor γ2 subunit. Mice with γ2 subunit F77I point mutation (γ2I77 mouse line) lose the high-affinity nanomolar binding of these ligands as well as their most robust behavioral actions at low doses. Interestingly, the γ2I77 mice offer a tool to study the actions of these substances mediated via other possible binding sites of the GABAA receptor. In ligand autoradiographic experiments, we discovered in γ2I77 mouse brain sections a significant amount of residual non-γ2 subunit-dependent benzodiazepine site binding enriched to the striatum and septum. Zolpidem only weakly affected this residual binding at micromolar concentrations, and only a high zolpidem dose (≥40mg/kg) caused sedation and deficits in motor coordination in γ2I77 mice. DMCM had an agonistic action through a secondary, low-affinity non-benzodiazepine binding site of the GABAA receptor in the forebrain of γ2I77 mice, and this drug also fully displaced the residual benzodiazepine-site labeling. In behavioral tests, a high dose (20mg/kg) of DMCM was sedative and modulated fear learning. DMCM, but not zolpidem, acted as an agonist in recombinant GABAA α1/6β3 receptors studied using ligand binding and electrophysiological assays. Our results highlight the less well-known actions of high doses of DMCM and zolpidem that are not mediated via the γ2 subunit-containing benzodiazepine site of the GABAA receptor. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
22. Ligand-binding Domain Determines Endoplasmic Reticulum Exit of AMPA Receptors.
- Author
-
Coleman, Sarah K., Möykkynen, Tommi, Hinkkuri, Sami, Vaahtera, Lauri, Korpi, Esa R., Pentikäinen, Olli T., and Keinänen, Kari
- Subjects
- *
ION channels , *GLUTAMIC acid , *NEURONS , *CELL membranes , *ENDOPLASMIC reticulum , *CELL membrane formation - Abstract
AMPA receptors (AMPARs) are tetrameric ion channels that mediate rapid glutamate signaling in neurons and many non-neuronal cell types. Endoplasmic reticulum (ER) quality control mechanisms permit only correctly folded functional receptors to be delivered to the cell surface. We analyzed the biosynthetic maturation and transport of all 12 GluA1-4 subunit splice variants as homomeric receptors and observed robust isoform-dependent differences in ER exit competence and surface expression. In contrast to inefficient ER exit of both GluA3 splice forms and the flop variants of GluA1 and GluA4, prominent plasma membrane expression was observed for the other AMPAR isoforms. Surprisingly, deletion of the entire N-terminal domain did not alter the transport phenotype, nor did the different cytosolic C-terminal tail splice variants. Detailed analysis of mutant receptors led to the identification of distinct residues in the ligand-binding domain as primary determinants for isoform-specific maturation. Considered together with the essential role of bound agonist, our findings reveal the ligand-binding domain as the critical quality control target in AMPAR biogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
23. Human locus coeruleus neurons express the GABAA receptor γ2 subunit gene and produce benzodiazepine binding
- Author
-
Hellsten, Kati S., Sinkkonen, Saku T., Hyde, Thomas M., Kleinman, Joel E., Särkioja, Terttu, Maksimow, Anu, Uusi-Oukari, Mikko, and Korpi, Esa R.
- Subjects
- *
LOCUS coeruleus , *GENE expression , *GABA receptors , *BENZODIAZEPINES , *NORADRENERGIC neurons , *VIGILANCE (Psychology) - Abstract
Abstract: Noradrenergic neurons of the locus coeruleus project throughout the cerebral cortex and multiple subcortical structures. Alterations in the locus coeruleus firing are associated with vigilance states and with fear and anxiety disorders. Brain ionotropic type A receptors for γ-aminobutyric acid (GABA) serve as targets for anxiolytic and sedative drugs, and play an essential regulatory role in the locus coeruleus. GABAA receptors are composed of a variable array of subunits forming heteropentameric chloride channels with different pharmacological properties. The γ2 subunit is essential for the formation of the binding site for benzodiazepines, allosteric modulators of GABAA receptors that are clinically often used as sedatives/hypnotics and anxiolytics. There are contradictory reports in regard to the γ2 subunit''s expression and participation in the functional GABAA receptors in the mammalian locus coeruleus. We report here that the γ2 subunit is transcribed and participates in the assembly of functional GABAA receptors in the tyrosine hydroxylase-positive neuromelanin-containing neurons within postmortem human locus coeruleus as demonstrated by in situ hybridization with specific γ2 subunit oligonucleotides and autoradiographic assay for flumazenil-sensitive [3H]Ro 15-4513 binding to benzodiazepine sites. These sites were also sensitive to the α1 subunit-preferring agonist zolpidem. Our data suggest a species difference in the expression profiles of the α1 and γ2 subunits in the locus coeruleus, with the sedation-related benzodiazepine sites being more important in man than rodents. This may explain the repeated failures in the transition of novel drugs with a promising neuropharmacological profile in rodents to human clinical usage, due to intolerable sedative effects. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
24. Brain regional distribution of GABAA receptors exhibiting atypical GABA agonism: Roles of receptor subunits
- Author
-
Halonen, Lauri M., Sinkkonen, Saku T., Chandra, Dev, Homanics, Gregg E., and Korpi, Esa R.
- Subjects
- *
GABA receptors , *CHEMICAL inhibitors , *THIOSULFATES , *BINDING sites , *BRAIN imaging , *AUTORADIOGRAPHY - Abstract
Abstract: The major inhibitory neurotransmitter in the brain, γ-aminobutyric acid (GABA), has only partial efficacy at certain subtypes of GABAA receptors. To characterize these minor receptor populations in rat and mouse brains, we used autoradiographic imaging of t-butylbicyclophosphoro[35S]thionate ([35S]TBPS) binding to GABAA receptors in brain sections and compared the displacing capacities of 10mM GABA and 1mM 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP), a competitive GABA-site agonist. Brains from GABAA receptor α1, α4, δ, and α4+δ subunit knockout (KO) mouse lines were used to understand the contribution of these particular receptor subunits to “GABA-insensitive” (GIS) [35S]TBPS binding. THIP displaced more [35S]TBPS binding than GABA in several brain regions, indicating that THIP also inhibited GIS-binding. In these regions, GABA prevented the effect of THIP on GIS-binding. GIS-binding was increased in the cerebellar granule cell layer of δ KO and α4+δ KO mice, being only slightly diminished in that of α1 KO mice. In the thalamus and some other forebrain regions of wild-type mice, a significant amount of GIS-binding was detected. This GIS-binding was higher in α4 KO mice. However, it was fully abolished in α1 KO mice, indicating that the α1 subunit was obligatory for the GIS-binding in the forebrain. Our results suggest that native GABAA receptors in brain sections showing reduced displacing capacity of [35S]TBPS binding by GABA (partial agonism) minimally require the assembly of α1 and β subunits in the forebrain and of α6 and β subunits in the cerebellar granule cell layer. These receptors may function as extrasynaptic GABAA receptors. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
25. Ethanol increases desensitization of recombinant GluR-D AMPA receptor and TARP combinations
- Author
-
Möykkynen, Tommi P., Coleman, Sarah K., Keinänen, Kari, Lovinger, David M., Korpi, Esa R., Möykkynen, Tommi P, and Keinänen, Kari
- Subjects
- *
PSYCHOLOGY of alcoholism , *DESENSITIZATION (Psychotherapy) , *RECOMBINANT proteins , *PROPIONIC acid , *CELL receptors , *CELLULAR control mechanisms , *EMBRYONIC stem cells , *CELL membranes , *PATCH-clamp techniques (Electrophysiology) , *BIOLOGICAL transport , *CALCIUM , *CELL lines , *COMPARATIVE studies , *ETHANOL , *RESEARCH methodology , *MEDICAL cooperation , *MEMBRANE proteins , *RESEARCH , *EVALUATION research , *EXCITATORY amino acid agonists , *EXCITATORY amino acid antagonists , *PHYSIOLOGY - Abstract
Abstract: Glutamate receptors are important target molecules of the acute effect of ethanol. We studied ethanol sensitivity of homomeric GluR-D receptors expressed in human embryonic kidney 293 cells and examined whether recently discovered transmembrane α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor regulatory proteins (TARPs) affect ethanol sensitivity. Coexpression of the TARPs, stargazin, and γ4 increased the time constant (τ-value) of current decay in the presence of agonist, thus slowing the onset of desensitization and increasing the steady-state current. Ethanol produced less inhibition of the peak current than the steady-state current for all types of the GluR-D receptors. In addition, ethanol concentration-dependently accelerated the rate of desensitization, measured as the τ-value of fast decay of peak current. This effect was enhanced with coexpression of TARPs. The recovery from desensitization was slowed down by coexpression of γ4 but ethanol did not affect this process in any GluR-D combination. The results support the idea that increased desensitization is an important mechanism in the ethanol inhibition of AMPA receptors and indicate that coexpression of TARPs can alter this effect of ethanol. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
26. Reduced benzodiazepine tolerance, but increased flumazenil-precipitated withdrawal in AMPA-receptor GluR-A subunit-deficient mice
- Author
-
Aitta-aho, Teemu, Vekovischeva, Olga Y., Neuvonen, Pertti J., and Korpi, Esa R.
- Subjects
- *
PHARMACODYNAMICS , *DRUG tolerance , *BENZODIAZEPINES , *GLUTAMIC acid , *MUSCLE relaxants , *FLURAZEPAM , *LABORATORY mice - Abstract
Abstract: Pharmacotherapy with benzodiazepines is compromised by rapid sedative tolerance and diverse withdrawal symptoms. To assess the role of AMPA-type glutamate receptor GluR-A subunits in neuroadaptation to subchronic benzodiazepine treatment, GluR-A subunit-deficient mice were rendered tolerant by a high-dose seven-day flurazepam treatment (40 mg/kg, s.c., twice a day for 4 days, 60 mg/kg twice a day for 3 days). The acute effects to flurazepam were not changed in the GluR−/− mice compared with their littermate control mice. GluR-A−/− mice developed less tolerance than their controls as demonstrated in behavioral tests for muscle relaxation and sensory functions. Actually, the knockout mice exhibited slower recovery than their littermates from impaired gait and pelvic position after an acute 40 mg/kg dose of flurazepam. The apparent elimination of flurazepam was similarly increased in the knockout and control mice as assessed by blood and brain concentrations 2 h after acute and chronic treatments, but the active metabolite desalkylflurazepam cumulated similarly in both mouse lines. Withdrawal symptoms, precipitated by flumazenil (20 mg/kg, s.c.) 48 h after discontinuation of the flurazepam treatment, were enhanced in the GluR-A−/− mice. The results stress the importance of the AMPA-receptor system in neuroadaptation to acute and chronic effects of benzodiazepines. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
27. Lifelong ethanol consumption and brain regional GABAA receptor subunit mRNA expression in alcohol-preferring rats
- Author
-
Sarviharju, Maija, Hyytiä, Petri, Hervonen, Antti, Jaatinen, Pia, Kiianmaa, Kalervo, and Korpi, Esa R.
- Subjects
- *
MESSENGER RNA , *RNA , *GABA , *ALCOHOL - Abstract
Abstract: Brain regional γ-aminobutyric acid type A (GABAA) receptor subunit mRNA expression was studied in ethanol-preferring AA (Alko, Alcohol) rats after moderate ethanol drinking for up to 2 years of age. In situ hybridization with oligonucleotide probes specific for 13 different subunits was used with coronal cryostat sections of the brains. Selective alterations were observed by ethanol exposure and/or aging in signals for several subunits. Most interestingly, the putative highly ethanol-sensitive α4 and β3 subunit mRNAs were significantly decreased in several brain regions. The age-related alterations in α4 subunit expression were parallel to those caused by lifelong ethanol drinking, whereas aging had no significant effect on β3 subunit expression. The results suggest that prolonged ethanol consumption leading to blood concentrations of about 10mM may downregulate the mRNA expression of selected GABAA receptor subunits and that aging might have partly similar effects. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
28. AMPA/kainate receptor-mediated up-regulation of GABAA receptor δ subunit mRNA expression in cultured rat cerebellar granule cells is dependent on NMDA receptor activation
- Author
-
Salonen, Virpi, Kallinen, Sampsa, Lopez-Picon, Francisco R., Korpi, Esa R., Holopainen, Irma E., and Uusi-Oukari, Mikko
- Subjects
- *
GABA , *MESSENGER RNA , *PROPIONIC acid , *METHYL aspartate - Abstract
Abstract: We have studied the effects of AMPA/kainate receptor agonists on GABAA receptor subunit mRNA expression in vitro in cultured rat cerebellar granule cells (CGCs). Kainate (KA) (100 μM) and high K+ (25 mM) dramatically up-regulated δ subunit mRNA expression to 500–700% of that in control cells grown in low K+ (5 mM). KA or high K+ had no effect on the expression of the other major GABAA receptor subunits α1, α6, β2, β3 or γ2. Up-regulation of δ mRNA was also detected with the AMPA receptor-selective agonist CPW-399 and to a lesser extent with the KA receptor-selective agonist ATPA. AMPA/kainate receptor-selective antagonist DNQX completely inhibited KA-, CPW-399- and ATPA-induced δ mRNA up-regulation indicating that the effects were mediated via AMPA and KA receptor activation. NMDA receptor-selective antagonist MK-801 inhibited 76% of the KA- and 57% of the CPW-399-induced δ up-regulation suggesting that KA and CPW-399 treatments may induce glutamate release resulting in NMDA receptor activation, and subsequently to δ mRNA up-regulation. In CGCs, δ subunit is a component of extrasynaptic α6βδ receptors that mediate tonic inhibition. Up-regulation of δ during prolonged glutamate receptor activation or cell membrane depolarization may be a mechanism to increase tonic inhibition to counteract excessive excitation. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
29. α2A-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice
- Author
-
Juhila, Juuso, Honkanen, Aapo, Sallinen, Jukka, Haapalinna, Antti, Korpi, Esa R., and Scheinin, Mika
- Subjects
- *
DOPAMINE , *LABORATORY mice , *AMPHETAMINE abuse , *AMPHETAMINES - Abstract
Abstract: Stimulants, such as d-amphetamine, enhance the release of dopamine in the central nervous system (CNS) and induce locomotor activation in mice. When amphetamine is administered repeatedly, the locomotor activation is progressively increased. This behavioural sensitization may be associated with the development of drug craving, addiction and dependence. Also noradrenergic mechanisms participate in the mediation of the effects of psychostimulants. In this study we show that mice lacking the α2-adrenoceptor subtype A (α2A-AR knock-out (KO) on C57Bl/6J background) are supersensitive to the acute locomotor effects of d-amphetamine (5 mg/kg) in a novel environment compared to wild-type (WT) control mice. When both genotypes were treated repeatedly with d-amphetamine (2 mg/kg) they developed locomotor hyperactivation (sensitization), but its amplitude was lower in α2A-AR KO mice. Development of hyperactivation was reduced in both genotypes by pretreatment with the selective α2-adrenoceptor antagonist, atipamezole (1 mg/kg). Acute atipamezole also attenuated the expression of d-amphetamine-induced behavioural sensitization especially in WT mice. Interestingly, α2A-AR KO mice failed to exhibit persistent sensitization after 2 weeks of abstinence from repeated d-amphetamine. Rewarding properties of d-amphetamine, measured by conditioned place preference, were similar in both genotypes. These findings indicate that d-amphetamine-induced acute and sensitized locomotor effects are controlled by α2-adrenoceptors. Drugs antagonizing the α2A-adrenoceptor subtype may provide a novel approach for reducing drug sensitization and motor complications caused by dopaminergic agents. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
30. Autoradiographic imaging of altered synaptic αβγ2 and extrasynaptic αβ GABAA receptors in a genetic mouse model of anxiety
- Author
-
Sinkkonen, Saku T., Lüscher, Bernhard, Lüddens, Hartmut, and Korpi, Esa R.
- Subjects
- *
GABA , *ANIMAL models in research , *AUTORADIOGRAPHY , *LIGANDS (Biochemistry) - Abstract
To image the possible alterations in brain regional GABAA receptor subtype properties in a genetic animal model of human anxiety, mice heterozygous for the deletion of GABAA receptor γ2 subunit (γ2+/−) were studied using ligand autoradiographic assays on brain cryostat sections. The [
35S ]TBPS binding assay was designed to reveal impaired GABA and channel site coupling shown to be more prominent in recombinant α1/6β3 than in α1/2β3γ2 or β2 subunit-containing GABAA receptors expressed in HEK 293 cells. Increased GABA-insensitive [35S ]TBPS binding in the γ2+/− mouse brains was evident in the cerebral cortex and in subcortical regions, the alterations being regionally similar to the loss of γ2 subnunit-dependent benzodiazepine (BZ) sites as revealed by [3H ]Ro 15-4513 autoradiography. As the γ2 subunit protein is needed for synaptic clustering of GABAA receptors, these results indicate that the extrasynaptic αβ3 receptors can be visualized in vitro as atypical GABA-insensitive [35S ]TBPS binding sites.The results suggest that GABAAergic synaptic inhibition is widely decreased in the brains of anxiety-prone γ2+/− mice, while extrasynaptic GABAA receptors are increased. These autoradiographic imaging findings further demonstrate the need to develop GABAA receptor subtype-selective in vivo ligands to aid in assessing the contributions of various subcellular receptor populations in anxious and other patient groups. [Copyright &y& Elsevier]- Published
- 2004
- Full Text
- View/download PDF
31. Comparison of deramciclane to benzodiazepine agonists in behavioural activity of mice and in alcohol drinking of alcohol-preferring rats
- Author
-
Ingman, Kimmo, Sallinen, Jukka, Honkanen, Aapo, and Korpi, Esa R.
- Subjects
- *
ALCOHOL drinking , *NEUROTRANSMITTERS , *SUBSTANCE abuse , *SEROTONIN - Abstract
Interactions between alcohol and traditional benzodiazepine anxiolytics hamper the treatment of alcoholism-related anxiety disorders. Serotonin 5-HT2 receptor antagonists, such as deramciclane, are anxiolytic, and considering their pharmacological profile, they might benefit alcoholics with comorbid anxiety. We studied the effects of acute deramciclane (1, 3 and 10 mg/kg ip) on alcohol drinking of alcohol-preferring AA rats drinking 10% (vol/vol) ethanol solution in a 4-h limited-access paradigm. Thereafter, a 5-day repeated-treatment experiment was carried out, under corresponding test design, with deramciclane (3 mg/kg ip) as a test drug and midazolam (1 mg/kg ip) as a benzodiazepine reference compound. Deramciclane had no effect on alcohol consumption in either acute or repeated dosing study. Midazolam increased ethanol drinking, as expected, when administered on successive days. A modified functional observational battery (FOB) procedure was applied to study neurological, behavioural and autonomic effects induced by deramciclane (1–30 mg/kg po) and diazepam (1–30 mg/kg po) in mice at 30 min, 2 h and 4 h after dosing. Deramciclane had a mild dopamine D2 receptor antagonism-like effect at the highest dose. The effects of diazepam were predictable, myorelaxation-induced motor impairment and anxiolysis-related hyperlocomotion in a novel environment being the characteristic features at the two highest doses. Deramciclane appears to be a safe and well-tolerated drug and we suggest that it might be useful in the treatment of anxiety in alcoholics. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
32. Selective changes in gamma-aminobutyric acid type A receptor subunits in the hippocampus in spontaneously seizing rats with chronic temporal lobe epilepsy
- Author
-
Laurén, Hanna B., Pitkänen, Asla, Nissinen, Jari, Soini, Sanna L., Korpi, Esa R., and Holopainen, Irma E.
- Subjects
- *
GABA , *MESSENGER RNA , *HIPPOCAMPUS (Brain) , *EPILEPSY - Abstract
Changes in the structure and function of inhibitory GABAA receptors may contribute to epileptogenesis. We have used the in situ hybridization technique to study GABAA receptor α2, α4, β3 and γ2 subunit mRNA expression in the hippocampus of spontaneously seizing rats with chronic temporal lobe epilepsy. In control rats, all four subunit mRNAs were expressed in the hippocampal subregions but the intensity of expression varied significantly between the subfields. In epileptic rats, α2 expression was decreased in CA3c, and α4 in CA1, but β3 was increased in all subregions, in particular in the granule cell layer. Our results suggest that GABAA receptor undergoes region selective subunit changes during epileptogenesis in the hippocampus of rats with chronic temporal lobe epilepsy. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
33. Risperidone reduces limited access alcohol drinking in alcohol-preferring rats
- Author
-
Ingman, Kimmo, Honkanen, Aapo, Hyytiä, Petri, Huttunen, Matti O., and Korpi, Esa R.
- Subjects
- *
ALCOHOL , *RISPERIDONE - Abstract
An atypical antipsychotic drug risperidone reduced ethanol drinking of ethanol-preferring Alko, Alcohol (AA) rats in a limited access paradigm. Its effect was transient at a dose known to preferentially antagonize the 5-HT2 receptors (0.1 mg/kg, s.c.), but long-lasting when the dose was increased to 1.0 mg/kg that also blocks dopamine D2 receptors. Risperidone also reduced dose-dependently locomotor activity and limited access saccharin intake of the AA rats, indicating that its effect on ethanol drinking was not selective. Risperidone at 0.1 mg/kg given before four successive daily ethanol-drinking sessions significantly reduced the ethanol intake. These data from an animal model of high ethanol intake suggest that risperidone should be tested in various populations of alcoholics for reducing ethanol consumption. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
34. GABA A antagonists reveal binding sites for [ 35S]TBPS in cerebellar granular cell layer
- Author
-
Korpi, Esa R., Lüddens, Hartmut, and Seeburg, Peter H.
- Published
- 1992
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.